JOHANNESBURG - As President Cyril Ramaphosa get's ready to meet his US counterpart, Donald Trump.
South Africa remains at war with disease, with the country recording the highest HIV/Aids concentration in Southern Africa.
It's inevitable, that the country would come under immense strain, following USAID withdrawals.
But what does this mean for big pharma?
Dr Stavros Nicolaou, from the Aspen Pharma Group discussed the business implications with eNCA.